Solid Biosciences (SLDB) Current Leases (2018 - 2024)
Solid Biosciences (SLDB) has disclosed Current Leases for 7 consecutive years, with $1.7 million as the latest value for Q3 2024.
- Quarterly Current Leases fell 6.98% to $1.7 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Sep 2024, down 6.98% year-over-year, with the annual reading at $1.9 million for FY2023, 2.21% down from the prior year.
- Current Leases hit $1.7 million in Q3 2024 for Solid Biosciences, up from $525000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.9 million in Q4 2022 to a low of $33000.0 in Q2 2022.
- Historically, Current Leases has averaged $1.1 million across 5 years, with a median of $1.3 million in 2021.
- Biggest five-year swings in Current Leases: crashed 97.8% in 2022 and later soared 5515.15% in 2023.
- Year by year, Current Leases stood at $208000.0 in 2020, then skyrocketed by 507.21% to $1.3 million in 2021, then surged by 50.2% to $1.9 million in 2022, then fell by 2.21% to $1.9 million in 2023, then dropped by 7.39% to $1.7 million in 2024.
- Business Quant data shows Current Leases for SLDB at $1.7 million in Q3 2024, $525000.0 in Q2 2024, and $496000.0 in Q1 2024.